Phenol Topical Solution recalled for CGMP manufacturing deviations
Edge Pharma, LLC is recalling 1,861 vials of Phenol, Topical Solution (PF) 89%, 3 mL per vial, distributed nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source text does not report any illnesses, injuries, or adverse events. The recall is based on theoretical manufacturing compliance deviations without evidence of actual harm. This meets the criteria for Moderate severity.
Plain-English summary
Edge Pharma, LLC is voluntarily recalling Phenol, Topical Solution (PF) Multiple Dose Vial, 89%, 3 mL per vial (NDC 05446-1211-03) manufactured at 856 Hercules Drive, Colchester, Vermont. The recall involves 1,861 jars distributed nationwide and was initiated on December 6, 2021.
The recall was issued due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The FDA classified this as a Class II recall on January 24, 2022, and the recall was publicly announced via press release on February 2, 2022.
Affected lot codes and date ranges are: 07-2021-12@9 (07/22/21–08/11/21); 08-2021-11@10 (08/25/21–09/10/21); 08-2021-12@12 (09/07/21–10/06/21); 09-2021-22@5 (10/12/21–10/28/21); 10-2021-07@8 (10/25/21–10/28/21); 10-2021-08@4 (10/28/21–11/12/21); and 11-2021-01@7 (11/15/21–12/01/21). Consumers or healthcare providers with this product should contact Edge Pharma, LLC for instructions on return or disposal. The recall was terminated on June 7, 2023.
The recalled product
- Product
- Phenol, Topical Solution (PF) Multiple Dose Vial, 89%, 3 mL per vial, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, NDC 05446-1211-03
- Manufacturer
- Edge Pharma, LLC
- Category
- Drug — Topical Solution
- Affected units
- 1,861
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 56 recalled by Edge Pharma, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 56 products in this recall →Related recalls
Same manufacturer · Edge Pharma, LLC
See all →- ModerateProfound-PE Dental Gel Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
- SevereMVASI Sterile Ophthalmic Solution Lacks Assured Sterility
FDA (Drugs) · 2022-02-02
- ModerateLET Topical Gel drug recall for CGMP deviations
FDA (Drugs) · 2022-02-02
- SevereVancomycin HCl Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2022-02-02
- ModerateCSF-HC Otic Powder Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-02
Same hazard · cgmp deviation
See all →- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Clindamycin Phosphate Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09